Clinical Trial Update: PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer [Phase 1]

View source ↗

Summary

This entry reports the completion of a phase 1 clinical trial evaluating PV701 in patients with advanced or recurrent peritoneal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Cancer

Drugs mentioned

• PV701

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cancer | Phase 1 | Status: COMPLETED